Friday, March 25, 2016

BRIEF-Oxigene says receives European orphan drug designation for CA4P

* European commission has granted orphan drug designation to CA4P for treatment of gastro-entero-pancreatic neuroendocrine tumors


Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)